Cargando…
LPIN1 rhabdomyolysis: A single site cohort description and treatment recommendations
Individuals with LPIN1 deficiency have early recurrent, life-threatening rhabdomyolysis but the full phenotypic spectrum and optimal treatment of the disorder remains unknown. Here we report the clinical details and treatment outcomes of 6 patients from our health system. The average age of presenta...
Autores principales: | Kanderi, Navya, Kirmse, Brian, Regier, Debra S., Chapman, Kimberly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856908/ https://www.ncbi.nlm.nih.gov/pubmed/35242575 http://dx.doi.org/10.1016/j.ymgmr.2022.100844 |
Ejemplares similares
-
Molecular analysis of LPIN1 in Jordanian patients with rhabdomyolysis
por: Jaradat, Saied A., et al.
Publicado: (2015) -
Use of dexamethasone in acute rhabdomyolysis in LPIN1 deficiency
por: Yeganeh, Mehdi, et al.
Publicado: (2023) -
A rare case of pediatric recurrent rhabdomyolysis with compound heterogenous variants in the LPIN1
por: Che, Ruochen, et al.
Publicado: (2020) -
Detection of compound heterozygous variants in LPIN1 does not necessarily imply pathogenicity in a patient with rhabdomyolysis
por: Finsterer, Josef, et al.
Publicado: (2020) -
LPIN1 deficiency with severe recurrent rhabdomyolysis and persistent elevation of creatine kinase levels due to chromosome 2 maternal isodisomy
por: Meijer, I.A., et al.
Publicado: (2015)